176 related articles for article (PubMed ID: 31861000)
21. Efficacy, safety and predictive indicators of apatinib after multilines treatment in advanced nonsquamous nonsmall cell lung cancer: Apatinib treatment in nonsquamous NSCLC.
Wu D; Liang L; Nie L; Nie J; Dai L; Hu W; Zhang J; Chen X; Han J; Ma X; Tian G; Han S; Long J; Wang Y; Zhang Z; Xin T; Fang J
Asia Pac J Clin Oncol; 2018 Dec; 14(6):446-452. PubMed ID: 29573236
[TBL] [Abstract][Full Text] [Related]
22. Use of apatinib combined with pemetrexed for advanced ovarian cancer: A case report.
Sun H; Xiao M; Liu S; Shi R
Medicine (Baltimore); 2018 Jul; 97(27):e11036. PubMed ID: 29979376
[TBL] [Abstract][Full Text] [Related]
23. The Efficacy and Safety of Apatinib in Advanced Synovial Sarcoma: A Case Series of Twenty-One Patients in One Single Institution.
Wang Y; Lu M; Zhou Y; Zhou S; Yu X; Tang F; Luo Y; Zhang W; Duan H; Min L; Tu C
Cancer Manag Res; 2020; 12():5255-5264. PubMed ID: 32669874
[TBL] [Abstract][Full Text] [Related]
24. Apatinib monotherapy for advanced non-small cell lung cancer after the failure of chemotherapy or other targeted therapy.
Liu Z; Ou W; Li N; Wang SY
Thorac Cancer; 2018 Oct; 9(10):1285-1290. PubMed ID: 30126078
[TBL] [Abstract][Full Text] [Related]
25. Primary pleural synovial sarcoma: a rare cause of hemorrhagic pleural effusion.
Kumar S; Goyal K; Bhatt R; Bansal S; Mishra M
Adv Respir Med; 2021; 89(1):60-62. PubMed ID: 33471348
[TBL] [Abstract][Full Text] [Related]
26. Apatinib for the treatment of gastric cancer.
Geng R; Li J
Expert Opin Pharmacother; 2015 Jan; 16(1):117-22. PubMed ID: 25420417
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of the VEGFR2 inhibitor Apatinib for metastatic soft tissue sarcoma: Chinese cohort data from NCT03121846.
Liu X; Xu J; Li F; Liao Z; Ren Z; Zhu L; Shi Y; Zhao G; Bai X; Zhao J; Xing R; Teng S; Yang Y; Yang J
Biomed Pharmacother; 2020 Feb; 122():109587. PubMed ID: 31786466
[TBL] [Abstract][Full Text] [Related]
28. Clinical Efficacy and Safety of Apatinib for the Treatment of Patients with Metastatic, Recurrent Cervical Cancer after Failure of Radiotherapy and First-Line Chemotherapy: A Prospective Study.
Xia X; Jiang W; Qi W; Hong B; Zhao W
Oncol Res Treat; 2020; 43(12):649-655. PubMed ID: 33045704
[TBL] [Abstract][Full Text] [Related]
29. A Single-Arm, Phase II Study of Apatinib in Refractory Metastatic Colorectal Cancer.
Chen X; Qiu T; Zhu Y; Sun J; Li P; Wang B; Lin P; Cai X; Han X; Zhao F; Shu Y; Chang L; Jiang H; Gu Y
Oncologist; 2019 Jul; 24(7):883-e407. PubMed ID: 30877190
[TBL] [Abstract][Full Text] [Related]
30. Significant Efficacy of Apatinib in a Patient With Hepatocellular Carcinoma Lung Metastases After Liver Transplantation: A Case Report.
Yu Z; Liu W; Deng Y; Yao J; Tang H; Li H; Yang Y; Wang G; Chen G
Transplant Proc; 2018 Dec; 50(10):4042-4045. PubMed ID: 30577311
[TBL] [Abstract][Full Text] [Related]
31. Clinical study of apatinib in the treatment of stage IV osteogenic sarcoma after failure of chemotherapy.
Liao Z; Li T; Zhang C; Liu X; Xing R; Teng S; Yang Y; Zhao G; Bai X; Zhao J; Yang J
Cancer Biol Med; 2020 May; 17(2):501-512. PubMed ID: 32587785
[No Abstract] [Full Text] [Related]
32. A Case Report of Gastrointestinal Hemorrhage and Perforation During Apatinib Treatment of Gastric Cancer.
Li XF; Tan YN; Cao Y; Xu JH; Zheng S; Yuan Y
Medicine (Baltimore); 2015 Sep; 94(39):e1661. PubMed ID: 26426663
[TBL] [Abstract][Full Text] [Related]
33. Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma.
Zhao J; Lei J; Yu J; Zhang C; Song X; Zhang N; Wang Y; Zhang S
Invest New Drugs; 2020 Apr; 38(2):500-506. PubMed ID: 31650447
[TBL] [Abstract][Full Text] [Related]
34. Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance.
Li F; Zhu T; Cao B; Wang J; Liang L
Eur J Cancer; 2017 Oct; 84():184-192. PubMed ID: 28822888
[TBL] [Abstract][Full Text] [Related]
35. Multicenter phase II study of apatinib in non-triple-negative metastatic breast cancer.
Hu X; Cao J; Hu W; Wu C; Pan Y; Cai L; Tong Z; Wang S; Li J; Wang Z; Wang B; Chen X; Yu H
BMC Cancer; 2014 Nov; 14():820. PubMed ID: 25376790
[TBL] [Abstract][Full Text] [Related]
36. Apatinib and fractionated stereotactic radiotherapy for the treatment of limited brain metastases from primary lung mucoepidermoid carcinoma: A case report.
Yan H; Li X; Peng Y; Zhang P; Zou N; Liu X
Medicine (Baltimore); 2020 Oct; 99(43):e22925. PubMed ID: 33120847
[TBL] [Abstract][Full Text] [Related]
37. [Clinical efficacy and safety of apatinib combined with chemotherapy for osteosarcoma and soft tissue sarcoma with pulmonary metastasis].
Li SL; Yang QK; Chen P; Zheng K; Wang W; Pei Y; Zhang XJ
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):309-314. PubMed ID: 31014058
[No Abstract] [Full Text] [Related]
38. Significant partial response of metastatic intra-abdominal and pelvic round cell liposarcoma to a small-molecule VEGFR-2 tyrosine kinase inhibitor apatinib: A case report.
Dong M; Bi J; Liu X; Wang B; Wang J
Medicine (Baltimore); 2016 Aug; 95(31):e4368. PubMed ID: 27495042
[TBL] [Abstract][Full Text] [Related]
39. Treatment of uterine high-grade endometrial stromal sarcoma with apatinib combined with chemotherapy: A case report.
Zhang Y; Chen C; Ren M; Cong X; Li Z; Yang L
Medicine (Baltimore); 2019 Mar; 98(13):e15050. PubMed ID: 30921232
[TBL] [Abstract][Full Text] [Related]
40. Apatinib treatment combined with chemotherapy for advanced epithelial ovarian cancer: a case report.
Deng L; Wang Y; Lu W; Liu Q; Wu J; Jin J
Onco Targets Ther; 2017; 10():1521-1525. PubMed ID: 28352185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
